Skip to main content

ScienCell SARS-CoV-2 Test Gets FDA Emergency Use Authorization

NEW YORK – The US Food and Drug Administration announced Friday that ScienCell Research Laboratories received Emergency Use Authorization for its SARS-CoV-2 test.

The ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR Detection Kit is a qualitative test detecting the virus from nasal, nasopharyngeal, and oropharyngeal swabs, as well as bronchoalveolar lavage.

The test was designed following guidelines from the US Centers for Disease Control and Prevention and received EUA under recently expanded guidance from the FDA.

Based in Carlsbad, California, ScienCell provides cell-based products – including human and animal cells, cell culture media and reagents, and gene analysis tools ­– to the research community.